At the recent annual meeting of the European Society of Cardiology, the research teams at Harvard University and Oxford University reported the results of two large clinical trials: For middle-aged and elderly people with moderate cardiovascular risk and diabetes, there is little benefit in using aspirin to prevent cardiovascular… Continue Reading Aspirin walks down the altar? Two authoritative magazines issued “no benefit”!
“In the next few years, by targeting genomic variation, doctors will be able to cure a range of diseases such as Alzheimer’s disease, Parkinson’s disease, diabetes, and cancer. In fact, we can now imagine that our grandchildren, cancer, A noun will become very strange to them.” In June 2000,… Continue Reading It is difficult to get medicine by one target
2015: The European Medicines Agency recommends that children under the age of 12 ban the use of codeine drugs to treat children with coughs and colds; children and adolescents between the ages of 12 and 18 who have respiratory problems should not use codeine to treat coughs and colds.… Continue Reading Disable these cold medicines under the age of 18
As the largest organ of the human body, the skin protects the human body from harmful substances from the outside. But because of this, the skin is also the most vulnerable part. Every year, 300,000 people worldwide die from skin wounds. Most of these people die from wounds that… Continue Reading Wound cells transform into stem cells, perfect for repairing wounds
A variety of tumor immunotherapies that activate T cells are effective in treating many types of cancer. However, due to the existence of the blood-brain barrier, immune cells cannot effectively infiltrate brain tumors, which is also an important reason why immunotherapy is difficult to effect on glioblastoma. The blood-brain… Continue Reading Successfully cross the blood-brain barrier, will CAR-T become a new breakthrough in the treatment of brain cancer?
After the traditional anti-arthritic drug rofecoxib was found to have side effects of increasing the risk of thrombosis, the cardiovascular safety of another traditional painkiller, Voltaren (diclofenac), was also questioned. As a non-steroidal anti-inflammatory drug (NSAIDs), there have been no clinical trials to verify its side effects. Voltaren is… Continue Reading Taking the painkiller Voltaren to increase the risk of cardiovascular disease within 30 days
Hepatocellular carcinoma is the most common type of primary liver cancer. The main risk factors include cirrhosis caused by hepatitis B/C and alcoholic fatty liver. Most patients in developed countries can be diagnosed in the early or mid-term of the disease, and receive curative surgery, local ablation treatment. Despite… Continue Reading Nature’s latest publication: Analysis of the market for hepatocellular carcinoma drugs
At present, drug treatment is still the most basic and most common treatment for hyperthyroidism, and it is suitable for hyperthyroidism patients with mild disease and mild to moderate thyroid enlargement. Drugs should be treated if they are under 20 years of age, pregnant with hyperthyroidism, frail elderly or… Continue Reading Antithyroid drugs: methimazole & propylthiouracil
In order to treat a disease, doctors prescribe one or several drugs for symptomatic treatment, but sometimes these drugs may induce other diseases. In particular, the elderly have more diseases and more risks, especially the risk. For the safety of medication for the elderly, Europe, the United States and… Continue Reading Six avoidance of medication for the elderly
Traditional gene therapy and emerging gene editing therapy for Duchenne Muscular Dystrophy (DMD), which one is better? Some recent research may give us some new thinking. There are approximately 300,000 DMD patients worldwide. Due to the presence of mutations, patients are unable to produce dystrophin normally, causing atrophy… Continue Reading Traditional gene therapy vs. gene editing, who is the king of DMD treatment?